Human auricular fibrillation pathogenic gene, encoding protein and use thereof

A gene coding, atrial fibrillation technology, applied in genetic engineering, animal/human peptides, plant genetic improvement, etc., can solve problems such as undisclosed or reported human atrial fibrillation pathogenic genes, no disclosure or suggestion of KCNQ1, etc.

Inactive Publication Date: 2004-07-07
TONGJI UNIV +1
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, no association of KCNQ1 with human atrial fibrillation has been disclosed or implied
[0008] In conclusion, no human atrial fibrillation causative genes associated with human atrial fibrillation have been disclosed or reported prior to this application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human auricular fibrillation pathogenic gene, encoding protein and use thereof
  • Human auricular fibrillation pathogenic gene, encoding protein and use thereof
  • Human auricular fibrillation pathogenic gene, encoding protein and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0114] Mapping of Human Atrial Fibrillation Genes

[0115] Genomic DNA of peripheral blood leukocytes is extracted through standard procedures, and the present invention uses the second version of the ABI Prism polymorphic microsatellite linkage marker kit to scan the whole genome. First do rough positioning, and then do fine positioning of key areas. The microsatellites used for the fine positioning of key regions were selected from the Généthon linkage map, and the microsatellite amplification primers were synthesized according to the Généthon set.

[0116] Microsatellites were amplified by multiplex PCR with a reaction volume of 5 ul, containing 20 ng of genomic DNA, 3.0 mM MgCl, 5-15 pairs of primers (each primer concentration 0.04 uM) and 0.2 U AmpliTaq Gold™ enzyme (PerkinElmer Applied Biosystems). Use the Touchdown method to do PCR, and the PCR cycle is as follows: first, 94°C for 12min; then 94°C for 30sec, 63°C for 1min (each cycle decreases by 0.5°C), and 72°C for 1...

Embodiment 2

[0120] Identification of Human Atrial Fibrillation Genes

[0121] The strategy adopted in the present embodiment to identify human atrial fibrillation pathogenic genes is: (1) in the positioning interval, first check whether the known ion channel genes (including genes such as KCNQ1 and CHRNA10) have mutations; (2) if No mutations are found in the known ion channel genes, and DNA fragments that are highly homologous to known ion channel genes will be searched in the positioning interval, and then these fragments will be used as probes to screen the cardiac cDNA library to clone new ion channels Next, detect whether these newly cloned ion channel genes are mutated in the family; (3) If no mutations are found in these known ion channel genes and newly cloned ion channel genes, then the arrhythmia The pathophysiological mechanism of the disease, determine other candidate genes that fall in this interval, and conduct mutation detection, and finally clone the pathogenic gene of idi...

Embodiment 3

[0139] Establishment of Hereditary Atrial Fibrillation Mouse Model Using Knock-in Technology

[0140] In this example, an animal model of hereditary atrial fibrillation was established by gene knock-in, and the atrial fibrillation-inducing effect of the S140G mutation was confirmed in the animals.

[0141] Comparing the homology of the human and mouse KCNQ1 genes, it is found that the KCNQ1 gene is highly conserved, and exons 1-8 in humans correspond to exons 2-9 in mice. The exon corresponds to the mouse exon 2, its nucleotide homology is 90%, and its amino acid homology is 100%. Therefore, changing the A to G in the 32nd nucleotide of exon 2 in mice should cause hereditary atrial fibrillation in mice.

[0142] Through restriction analysis of the genome sequence of the mouse KCNQ1 gene, the two homologous recombination arms used for gene targeting were designed between the 2nd and 3rd exons (including part of the 2nd exon), that is, the 5' arm 44807-47832, 3'arm 40739-43790...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A human pathogenic gene of auricular fibrillation, which is a mutant of KCNQ1 gene, its nucleotide sequence and coded protein, and its preparing process and application are disclosed. The preparing process and application of its cell model and animal model, and the KCNQ1S14OG-KCNE1(Iks) composition with function gain are also disclosed.

Description

technical field [0001] The invention relates to the fields of molecular genetics, cell biology, model biology, molecular pharmacology and cardiology. Specifically, the present invention relates to human atrial fibrillation pathogenic gene and its encoded protein. In addition, the present invention also relates to the preparation method and application of the human atrial fibrillation pathogenic gene nucleotide sequence and encoded protein. The invention particularly relates to the preparation method and application of the cell model and animal model transfected with the human atrial fibrillation pathogenic gene. Background technique [0002] According to the definition of the World Health Organization, atrial fibrillation (atrial fibrillation) is irregular and chaotic electrical activity in the atrium. Complete ventricular rate variability in the absence of high-grade or complete AV block. [0003] Atrial fibrillation is one of the most common clinical arrhythmias, which ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A01K67/00C07H21/00C07K14/435C07K14/47C12N15/12C12N15/63C12P21/02C12Q1/68G01N33/68
Inventor 陈义汉黄薇徐世杰徐文渊谢陪俐
Owner TONGJI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap